ATOX1 and cancer: As ATOX1 is a crucial intracellular copper chaperone, ATOX1 inhibition in cancer cells increases total cellular copper and ROS levels, which is associated with decreased SOD1 activity and ATP synthesis as well as lower NADPH and GSH levels, leading to impaired ROS clearance [72].